Copyright © 2001 by the European Society of Cardiology.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hotline Editorial
Clinical, public health, and research implications of the Heart Outcomes Prevention Evaluation (HOPE) Study
Division of Cardiology and Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
References
- N Engl J Med. 2000;342:145153
[Abstract/Free Full Text] - N Engl J Med. 2000;342:154160
[Abstract/Free Full Text] - Flather MD, Yusuf S, Kober L. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet. 2000;355:15751581[CrossRef][ISI][Medline]
- Lonn E, Yusuf S, Jha P. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation. 1994;4:20562069
- Lonn EM, Dzavik V, Yusuf S. Results of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation. 1999;100:I185
- Sleight P, Yusuf S, Pogue J. Reduction of events by ramipril in high-risk subjects is largely unrelated to blood pressure decrease. Presented at the 49th Annual Scientific Session of the American Congress of Cardiology, March 1215, 2000. Anaheim (CA). J Am Coll Cardiol. 2000;35:284A
- Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ. 1989;299:11871192[ISI][Medline]
- N Engl J Med. 1994;330:10291035
[Abstract/Free Full Text] - Lancet. 1999;354:447455[CrossRef][ISI][Medline]
This article has been cited by other articles:
![]() |
M. W Clarke, N. C Ward, J. H. Wu, J. M Hodgson, I. B Puddey, and K. D Croft Supplementation with mixed tocopherols increases serum and blood cell {gamma}-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes Am. J. Clinical Nutrition, January 1, 2006; 83(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
